MacroGenics
MGNX
#8656
Rank
โ‚น19.33 B
Marketcap
โ‚น304.21
Share price
2.24%
Change (1 day)
120.25%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2025 (TTM): -โ‚น4.98

According to MacroGenics's latest financial reports the company's current EPS (TTM) is -โ‚น4.75. In 2024 the company made an earnings per share (EPS) of -โ‚น101.72 a decrease over its 2023 EPS that were of -โ‚น14.26.

EPS history for MacroGenics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น4.98-95.1%
2024-โ‚น101.72613.33%
2023-โ‚น14.26-92.31%
2022-โ‚น185.38-42.14%
2021-โ‚น320.3836.44%
2020-โ‚น234.82-21.84%
2019-โ‚น300.41-24.58%
2018-โ‚น398.33675.93%
2017-โ‚น51.34-68.05%
2016-โ‚น160.66168.25%
2015-โ‚น59.89-55%
2014-โ‚น133.093400%
2013-โ‚น3.80-108.68%
2012โ‚น43.8224.49%
2011โ‚น35.20

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น129.29-2,820.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,189-46,148.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,362-28,760.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น651.21-13,800.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น694.97-14,720.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น328.93-7,020.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-โ‚น168.27 3,440.00%๐Ÿ‡บ๐Ÿ‡ธ USA